Review Article
Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis
Table 3
Summary of miRs with altered expression, their potential targets, and pathways entered this study.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AKT, AKT serine/threonine kinase; BTG2, B cell translocation gene 2; E2F1, E2F transcription factor 1; EGFR, epidermal growth factor receptor; FGFRL1, fibroblast growth factor receptor-like 1; FOXO3a, forkhead box O3; HIF-1a, hypoxia-inducible factor 1a; HOX, homeobox; MIG6, mitogen-inducible gene 6; MITF-M, microphthalmia-associated transcription factor-M; MMP-3, matrix metalloproteinase-3; NRP, nitrogen regulatory protein; PDCD4, programmed cell death 4; PTEN, protein tyrosine phosphatase; RHOC, ras homolog family member C; RND3, rho family GTPase 3; STA3, signal transducers and activators of transcription; TIMP-2, tissue inhibitor of metalloproteinases-2; TSP-1, thrombospondin-1; uPA, urokinase-type plasminogen activator. |